Predictions
Aphria Inc.
Start price
Target price
Perf. (%)
€13.38
08.03.21
08.03.21
€15.00
13.62%
10.03.21
10.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€20.95
10.02.21
10.02.21
€22.00
11.75%
11.02.21
11.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€7.48
11.01.21
11.01.21
-
11.01.22
11.01.22
39.14%
15.01.21
15.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.20
07.11.20
07.11.20
€6.40
23.49%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.55
16.11.20
16.11.20
€105.00
16.11.21
16.11.21
-10.40%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Aphria Inc.
Start price
Target price
Perf. (%)
€4.90
14.11.20
14.11.20
-
14.11.21
14.11.21
23.24%
27.11.20
27.11.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Trillium Therapeutics
Start price
Target price
Perf. (%)
€8.76
22.08.20
22.08.20
-
07.09.20
07.09.20
-5.48%
07.09.20
07.09.20
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€3.70
24.05.20
24.05.20
€5.00
26.06.20
26.06.20
-0.54%
26.06.20
26.06.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€42.32
29.01.19
29.01.19
€23.00
12.05.20
12.05.20
-66.80%
12.05.20
12.05.20
Aptose Biosciences
Start price
Target price
Perf. (%)
€1.81
26.05.19
26.05.19
€2.71
05.07.19
05.07.19
49.91%
05.07.19
05.07.19
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.73
03.06.19
03.06.19
€2.35
20.06.19
20.06.19
36.98%
20.06.19
20.06.19
Could be worthwhile Investment >10% per year
Aphria Inc.
Start price
Target price
Perf. (%)
€7.73
16.04.19
16.04.19
€10.00
17.04.19
17.04.19
-6.47%
17.04.19
17.04.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€8.65
15.02.19
15.02.19
€10.00
13.03.19
13.03.19
-2.31%
13.03.19
13.03.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.89
08.02.18
08.02.18
€7.31
08.02.19
08.02.19
16.24%
08.02.19
08.02.19
Aphria Inc.
Start price
Target price
Perf. (%)
€6.14
24.01.19
24.01.19
€10.00
05.02.19
05.02.19
63.36%
05.02.19
05.02.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.59
11.01.19
11.01.19
€7.00
16.01.19
16.01.19
7.16%
16.01.19
16.01.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.02
28.12.18
28.12.18
€7.00
02.01.19
02.01.19
0.00%
02.01.19
02.01.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.05
27.12.18
27.12.18
€10.00
27.12.18
27.12.18
-0.99%
27.12.18
27.12.18
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected